Renal Pathology 5 Flashcards
what is nephrosclerosis?
sclerosis of the renal arterioles and small arteries
what is nephrosclerosis strongly associated with?
hypertension
how do the kidney appear in cases of nephrosclerosis?
the kidneys are either normal or moderately reduced in size; the cortical surfaces have a fine, even granularity
hypertension secondary to renal artery stenosis is due to what?
increased production of renin from the ischemic kidney
in cases of renal artery stenosis, what class of drug would you use to treat the resultant elevation in renin with?
ARBs- aka drugs that block angiotensin II
what is fibromuscular dysplasia?
a focal irregular thickening in medium and large muscular arteries including renal, carotid arteries
what demographic of patient is FMD more commonly seen?
women in their 3rd-4th decade of life
what can FMD lead to?
aneurysms, which can then rupture
what are the two forms of thrombotic microangiopathy we discussed?
thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS)
what is typical HUS?
most frequently associated with the consumption of food contaminated by e. coli O157:H7
who is most at risk for typical HUS?
children and older adults
what are the signs and symptoms of typical HUS?
following an episode of diarrhea, increased bleeding tendencies, renal failure, microangiopathic hemolytic anemia, thrombocytopenia, and neurologic changes
more than half of those affected with atypical HUS have an inherited deficiency in what?
complement regulatory proteins, such as factor H, factor I, and CD46
if a patient has atypical HUS that is not caused by an inherited deficiency in complement regulatory proteins, what might they have instead?
antiphospholipid syndrome (either primary or secondary to lupus), complications of pregnancy or postpartum, systemic sclerosis, malignant hypertension, chemotherapeutic and immunosuppressive agents, or irradiation of the kidney
what are 5 examples of chemotherapeutic and immunosuppressive drugs that could lead to atypical HUS?
mitomycin, cyclosporine, cisplatin, gemcitabine, and antagonists of VEGF